Integrating In Vitro and In Vivo Genomic Data in Cancer Research
Author Information
Author(s): Laila M. Poisson, Debashis Ghosh
Primary Institution: University of Michigan
Hypothesis
Can gene signatures from in vitro experiments predict clinical outcomes in in vivo cancer samples?
Conclusion
The study demonstrates that in vitro gene signatures can effectively predict clinical outcomes in various cancer types.
Supporting Evidence
- The in vitro gene signature was derived from a wound healing study.
- Significant correlations were found between in vitro and in vivo gene expression profiles.
- Permutation testing showed that the in vitro signature outperformed random gene sets.
Takeaway
Scientists are trying to see if results from lab tests on cells can help predict how real tumors behave in patients.
Methodology
The study used gene expression profiling and statistical tests to compare in vitro and in vivo data.
Potential Biases
Potential bias due to the selection of genes and the use of different datasets.
Limitations
The study's findings may be limited by the differences in microarray platforms and gene mapping.
Participant Demographics
The study involved various cancer types including prostate, breast, and lung cancers.
Statistical Information
P-Value
p < 0.0001 for prostate tumors, p = 0.0207 for breast tumors, p = 0.0352 for lung tumors
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website